SE8400934L - Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner - Google Patents

Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner

Info

Publication number
SE8400934L
SE8400934L SE8400934A SE8400934A SE8400934L SE 8400934 L SE8400934 L SE 8400934L SE 8400934 A SE8400934 A SE 8400934A SE 8400934 A SE8400934 A SE 8400934A SE 8400934 L SE8400934 L SE 8400934L
Authority
SE
Sweden
Prior art keywords
lyophilized
adsorped
procedure
preparation
polyvalent vaccines
Prior art date
Application number
SE8400934A
Other languages
Unknown language ( )
English (en)
Other versions
SE463958B (sv
SE8400934D0 (sv
Inventor
Z Csizer
K Sikos
L Bacskai
I Joo
E Niedermayer
L Rethy
J Zsidai
Original Assignee
Human Oltoanyagtermelo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo filed Critical Human Oltoanyagtermelo
Publication of SE8400934D0 publication Critical patent/SE8400934D0/sv
Publication of SE8400934L publication Critical patent/SE8400934L/sv
Publication of SE463958B publication Critical patent/SE463958B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8400934A 1983-02-22 1984-02-21 Foerfarande foer framstaellning av lyofiliserade, adsorberade, polyvalenta vacciner SE463958B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU367783 1983-02-22

Publications (3)

Publication Number Publication Date
SE8400934D0 SE8400934D0 (sv) 1984-02-21
SE8400934L true SE8400934L (sv) 1984-08-23
SE463958B SE463958B (sv) 1991-02-18

Family

ID=10965021

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400934A SE463958B (sv) 1983-02-22 1984-02-21 Foerfarande foer framstaellning av lyofiliserade, adsorberade, polyvalenta vacciner

Country Status (2)

Country Link
RO (1) RO89832B (sv)
SE (1) SE463958B (sv)

Also Published As

Publication number Publication date
SE463958B (sv) 1991-02-18
SE8400934D0 (sv) 1984-02-21
RO89832B (ro) 1987-01-31
RO89832A (ro) 1987-01-30

Similar Documents

Publication Publication Date Title
ES8506451A1 (es) Procedimiento para preparar vacunas polivalentes adsorbidas y liofilizadas
DE3685519D1 (de) Influenzaimpfstoff.
FI953529A (sv) Vacciner innehållande ett gangliosid-KLH-konjugat och QS-21-substans
ATE119037T1 (de) Influenzaimpfstoff und adjuvanten.
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
BR9814473A (pt) Imunógenos anti-retrovirais, preparação e uso
DK120383A (da) Fremgangsmaade til fremstilling af konjugater af haptener og muramyl-peptider, der har immunogen virkning
ATE149569T1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
NO933856D0 (no) Pediatrisk kombinasjonsvaksine
SE8400934L (sv) Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner
NO892015D0 (no) Fremgangsmaate for fremstilling av et legemiddel.
CA1209036A (en) Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
RO76563A2 (ro) Procedeu de stabilizare a unui vaccin antiherpetic
DE69322960D1 (de) Empfängnisverhütender impfstoff
GB2001995A (en) An immunostimulant, a process for preparing it, and compositions containing it
IT1226728B (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
Géresi et al. The ontogenic development of antitoxin-producing capacity of humans and animals-- The immuno-modulation in immunization practice.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8400934-9

Effective date: 19920904

Format of ref document f/p: F